PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

191 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Endele, M. et al.: CSF-1-induced Src signaling can instruct monocytic lineage choice. Blood 129, 1691-1701 (2017)
42.
Canli, Ö.* et al.: Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127, 139-148 (2016)
43.
Jacobsen, C.* et al.: HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood 128, 2517-2526 (2016)
44.
Kokkaliaris, K.D. et al.: Identification of factors promoting ex vivo maintenance of mouse hematopoietic stem cells by long-term single-cell quantification. Blood 128, 1181-1192 (2016)
45.
Saito, Y.* et al.: Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice. Blood 128, 1829-1833 (2016)
46.
Stark, K.* et al.: Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435-2449 (2016)
47.
Toubiana, J.* et al.: Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype: An international survey of 274 patients from 167 kindreds. Blood 127, 3154-3164 (2016)
48.
Carlet, M. ; Vergalli, J. ; Finkenzeller, C. ; Grunert, M. & Jeremias, I.: The novel technique of Genetically Engineered Patient-Derived Xenografts (GEPDX) reveals that the X-linked Inhibitor of Apoptosis Protein (XIAP) plays an essential role for maintenance and growth of patients' acute lymphoblastic leukemia in vivo. Blood 126:2632 (2015)
49.
Deiser, K. et al.: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Blood 126:3805 (2015)
50.
Ebinger, S. et al.: Single cell RNA sequencing reveals increased adhesion signals in treatment-resistant tumor stem cells in a preclinical mouse model of genetically engineered patient-derived acute lymphoblastic leukemia. Blood 126:2630 (2015)
51.
Finkenzeller, C. ; Carlet, M. ; Vosberg, S.* ; Greif, P.A.* & Jeremias, I.: Functional diversity of single stem cell clones in patients' acute lymphoblastic leukemia growing in mice: An adverse subclone with distinct DNA-methylation pattern, slow growth in vivo and drug resistance. Blood 126:3062 (2015)
52.
Fischer, L. et al.: The novel CDK4/6-inhibitor abemaciclib induces early G1-arrest in MCL cell lines, sensitizes cells to cytarabine treatment and is additive with ibrutinib. Blood 126:5124 (2015)
53.
Freysoldt, B. et al.: Cotargeting of PIM, PI3K and Mtor in Mantle Cell Lymphoma (MCL). Blood 126:5120 (2015)
54.
Garz, A.-K.* et al.: Azacitidine in combination with the selective FLT3 kinase inhibitor crenolanib effectively disrupts stromal protection of CD34+Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML). Blood 126 (2015)
55.
Hofer, T.P. et al.: Slan-defined subsets of CD16-positive monocytes: Impact of granulomatous inflammation and M-CSF-receptor mutation. Blood 126, 2601-2610 (2015)
56.
Huffman, J.E.* et al.: Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood 126, e19-e29 (2015)
57.
Köhnke, T. et al.: Improved detection of minimal residual disease by flow cytometry in AML by combining manual gating and visne clustering. Blood 126:2593 (2015)
58.
Krupka, C. et al.: Identifying immune resistance mechanisms to CD33/CD3 BiTE® antibody construct (AMG 330) mediated cytotoxicity. Blood 126:3677 (2015)
59.
Murakami, M.A.* et al.: Proxe: A public repository of xenografts to facilitate studies of biology and expedite preclinical drug development in leukemia and lymphoma. Blood 126:3252 (2015)
60.
Reiter, K. et al.: Tyrosin kinase inhibition restores the membrane localization of FLT3-ITD. Blood 126 (2015)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮